Trial sizes are ideal for comparisons between suppliers or various application testings and cost effective at $99 US. Over 6,000 trial-sized antibodies are available to more than 3,300 protein targets, and new releases are continuing to be added every month.
Bethyl has applied B-cell sorting and recombinant DNA technology to our unparalleled on-site manufacturing process to deliver high quality recombinant rabbit monoclonal antibodies (RmAbs). Designed with a 100% guarantee to work in validated applications to ensure that you spend less time re-doing experiments and more time researching.
The hypoxic response pathway is triggered by low levels of oxygen in the cellular environment. Hypoxia inducible transcription factor (HIF) is central to the hypoxic response. The overexpression of HIF1-alpha and HIF2-alpha is associated with poor survival rates for various cancers. Bethyl has expanded its capabilities and now offers rabbit recombinant monoclonal antibodies to HIF1-alpha and HIF2-alpha.
Bethyl's purpose is to improve lives by supporting scientific discovery. This drives our complete dedication to the highest standards of product and service quality.
Bethyl is unique in our end-to-end control of the entire antibody lifecycle. From our veterinary facilities to the development, production and validation labs, the Bethyl team focuses on delivering quality products. This attention to quality at every step and the integration across each stage of the process means scientists can rely on Bethyl antibodies. We also offer expert technical support to help ensure your success.